What the latest studies show — and what they don’t — about the bivalent boosters’ effectiveness
In early September, the Centers for Disease Control and Prevention (CDC) recommended updated Covid-19 boosters for all Americans 12 and over.
The “update” was a broadening of the vaccines’ target: In addition to aiming for the initial strain of the virus, the new boosters would also take aim at the spike protein present on newer omicron variants of SARS-CoV-2, BA.4 and BA.5.
The hope was that the new boosters (called “bivalent,” for the two strains) would provide additional protection, priming the immune system…